MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Pfizer

Abierto

SectorSanidad

25.68 -2.21

Resumen

Variación precio

24h

Actual

Mínimo

25.71

Máximo

26.47

Métricas clave

By Trading Economics

Ingresos

-45M

2.9B

Ventas

938M

15B

P/B

Media del Sector

13.984

37.257

BPA

0.78

Rentabilidad por dividendo

6.21

Margen de beneficios

19.982

Empleados

81,000

EBITDA

266M

5.3B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+8.6% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

6.21%

2.94%

Próximas Ganancias

4 nov 2025

Fecha Próximo Dividendo

1 dic 2025

Próxima Fecha de Ex Dividendo

7 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

16B

150B

Apertura anterior

27.89

Cierre anterior

25.68

Noticias sobre sentimiento de mercado

By Acuity

36%

64%

150 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Pfizer Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 oct 2025, 08:54 UTC

Principales Movimientos del Mercado

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

30 sept 2025, 15:07 UTC

Principales Movimientos del Mercado

Pfizer Shares Rise After WSJ Reports Company Will Lower Drug Costs

22 sept 2025, 14:54 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- 2nd Update

22 sept 2025, 11:51 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 sept 2025, 11:09 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

22 sept 2025, 10:13 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Metsera Shares Leap Premarket on Report of Takeover by Pfizer

22 sept 2025, 07:42 UTC

Adquisiciones, fusiones, absorciones

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources

5 ago 2025, 11:34 UTC

Ganancias

Pfizer Boosts 2025 Adjusted EPS Outlook Following 2Q Gains

22 sept 2025, 15:17 UTC

Adquisiciones, fusiones, absorciones

Pfizer Jumps Back into the Weight-Loss Race With $4.9B Acquisition -- Barrons.com

22 sept 2025, 13:43 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 sept 2025, 11:26 UTC

Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Fox, Coinbase, Metsera, Pfizer, Kenvue, Anywhere Real Estate, Premier, and More -- Barrons.com

22 sept 2025, 11:26 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- WSJ

22 sept 2025, 10:48 UTC

Adquisiciones, fusiones, absorciones

Pfizer: Metsera Deal Adds Four Clinical-Stage Incretin, Amylin Programs to Pipeline >PFE MTSR

22 sept 2025, 10:47 UTC

Adquisiciones, fusiones, absorciones

Pfizer: Metsera Deal Includes Contingent Value Rights Worth Up to Additional $22.50/Share >PFE MTSR

22 sept 2025, 10:46 UTC

Adquisiciones, fusiones, absorciones

Pfizer: Metsera Deal Has Initial Enterprise Value of $4.9 Billion >PFE MTSR

22 sept 2025, 10:45 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Pay Initial $47.50/Share for Metsera >PFE MTSR

22 sept 2025, 10:45 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Acquire Metsera and Its Next-Generation Obesity Portfolio >PFE MTSR

22 sept 2025, 09:12 UTC

Acciones populares

Stocks to Watch Monday: Nippon Steel, Porsche, Infosys, Metsera -- WSJ

5 ago 2025, 20:44 UTC

Ganancias

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 ago 2025, 18:20 UTC

Ganancias

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 ago 2025, 18:17 UTC

Ganancias

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 ago 2025, 16:04 UTC

Charlas de Mercado

Pfizer's New Tax Rate Helps Boost Adj EPS Outlook -- Market Talk

5 ago 2025, 15:25 UTC

Ganancias

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 ago 2025, 13:56 UTC

Ganancias

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 ago 2025, 11:43 UTC

Ganancias

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs. -- Barrons.com

5 ago 2025, 11:27 UTC

Ganancias

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 ago 2025, 10:57 UTC

Ganancias

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. -- Barrons.com

5 ago 2025, 10:55 UTC

Ganancias

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 ago 2025, 10:53 UTC

Ganancias

Pfizer Boosts 2025 Profit Estimate In A Sign Of 'Confidence' -- MarketWatch

5 ago 2025, 10:51 UTC

Ganancias

Pfizer: On Track to Deliver About $7.2B Overall Cost Savings From Cost-Improvement Initiatives b/ End of 2027 >PFE

Comparación entre iguales

Cambio de precio

Pfizer previsión

Precio Objetivo

By TipRanks

8.6% repunte

Estimación a 12 Meses

Media 28.53 USD  8.6%

Máximo 34 USD

Mínimo 24 USD

De acuerdo con 17 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

17 ratings

4

Comprar

12

Mantener

1

Vender

Puntuación técnica

By Trading Central

22.855 / 23.85Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

150 / 371 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat